When capital is abundant, true industry expertise is a valuable resource. At HC9, we work closely with our Limited Partners and other industry leaders to guide and build the companies that will shape the future of healthcare.
We focus on Seed and Series A investments, as we recognize that outsized returns are produced at earlier stages of investment. HC9 draws upon our collective experience to provide the critical insights, relationships and expertise necessary for emerging companies to refine product-market fit and execute successful go-to-market strategies. The result is a meaningful inflection in the growth trajectory of our portfolio companies.